FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139510434> ?p ?o ?g. }

• W2139510434 endingPage "2685" @default.
• W2139510434 startingPage "2672" @default.
• W2139510434 abstract "To determine, in women with primary operable breast cancer, if preoperative doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan; AC) therapy yields a better outcome than postoperative AC therapy, if a relationship exists between outcome and tumor response to preoperative chemotherapy, and if such therapy results in the performance of more lumpectomies.Women (1,523) enrolled onto National Surgical Adjuvant Breast and Bowel Project (NSABP) B-18 were randomly assigned to preoperative or postoperative AC therapy. Clinical tumor response to preoperative therapy was graded as complete (cCR), partial (cPR), or no response (cNR). Tumors with a cCR were further categorized as either pathologic complete response (pCR) or invasive cells (pINV). Disease-free survival (DFS), distant disease-free survival (DDFS), and survival were estimated through 5 years and compared between treatment groups. In the preoperative arm, proportional-hazards models were used to investigate the relationship between outcome and tumor response.There was no significant difference in DFS, DDFS, or survival (P = .99, .70, and .83, respectively) among patients in either group. More patients treated preoperatively than postoperatively underwent lumpectomy and radiation therapy (67.8% v 59.8%, respectively). Rates of ipsilateral breast tumor recurrence (IBTR) after lumpectomy were similar in both groups (7.9% and 5.8%, respectively; P = .23). Outcome was better in women whose tumors showed a pCR than in those with a pINV, cPR, or cNR (relapse-free survival [RFS] rates, 85.7%, 76.9%, 68.1%, and 63.9%, respectively; P < .0001), even when baseline prognostic variables were controlled. When prognostic models were compared for each treatment group, the preoperative model, which included breast tumor response as a variable, discriminated outcome among patients to about the same degree as the postoperative model.Preoperative chemotherapy is as effective as postoperative chemotherapy, permits more lumpectomies, is appropriate for the treatment of certain patients with stages I and II disease, and can be used to study breast cancer biology. Tumor response to preoperative chemotherapy correlates with outcome and could be a surrogate for evaluating the effect of chemotherapy on micrometastases; however, knowledge of such a response provided little prognostic information beyond that which resulted from postoperative therapy." @default.
• W2139510434 created "2016-06-24" @default.
• W2139510434 creator A5011102928 @default.
• W2139510434 creator A5013706869 @default.
• W2139510434 creator A5014470885 @default.
• W2139510434 creator A5019140543 @default.
• W2139510434 creator A5024636761 @default.
• W2139510434 creator A5026911901 @default.
• W2139510434 creator A5040697066 @default.
• W2139510434 creator A5043776379 @default.
• W2139510434 creator A5049230032 @default.
• W2139510434 creator A5049493074 @default.
• W2139510434 creator A5055013606 @default.
• W2139510434 creator A5064069772 @default.
• W2139510434 creator A5073338995 @default.
• W2139510434 creator A5077277131 @default.
• W2139510434 creator A5078282647 @default.
• W2139510434 creator A5084017326 @default.
• W2139510434 date "1998-08-01" @default.
• W2139510434 modified "2023-10-18" @default.
• W2139510434 title "Effect of preoperative chemotherapy on the outcome of women with operable breast cancer." @default.
• W2139510434 cites W1795764517 @default.
• W2139510434 cites W1919403884 @default.
• W2139510434 cites W1955397179 @default.
• W2139510434 cites W1966623655 @default.
• W2139510434 cites W2024082259 @default.
• W2139510434 cites W2041613638 @default.
• W2139510434 cites W2047127173 @default.
• W2139510434 cites W2052025976 @default.
• W2139510434 cites W2055184641 @default.
• W2139510434 cites W2069886073 @default.
• W2139510434 cites W2096602429 @default.
• W2139510434 cites W2114252947 @default.
• W2139510434 cites W2123066352 @default.
• W2139510434 cites W2130649582 @default.
• W2139510434 cites W2138021040 @default.
• W2139510434 cites W2145874149 @default.
• W2139510434 cites W2148078311 @default.
• W2139510434 cites W2262955759 @default.
• W2139510434 cites W850470413 @default.
• W2139510434 doi "https://doi.org/10.1200/jco.1998.16.8.2672" @default.
• W2139510434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9704717" @default.
• W2139510434 hasPublicationYear "1998" @default.
• W2139510434 type Work @default.
• W2139510434 sameAs 2139510434 @default.
• W2139510434 citedByCount "1989" @default.
• W2139510434 countsByYear W21395104342012 @default.
• W2139510434 countsByYear W21395104342013 @default.
• W2139510434 countsByYear W21395104342014 @default.
• W2139510434 countsByYear W21395104342015 @default.
• W2139510434 countsByYear W21395104342016 @default.
• W2139510434 countsByYear W21395104342017 @default.
• W2139510434 countsByYear W21395104342018 @default.
• W2139510434 countsByYear W21395104342019 @default.
• W2139510434 countsByYear W21395104342020 @default.
• W2139510434 countsByYear W21395104342021 @default.
• W2139510434 countsByYear W21395104342022 @default.
• W2139510434 countsByYear W21395104342023 @default.
• W2139510434 crossrefType "journal-article" @default.
• W2139510434 hasAuthorship W2139510434A5011102928 @default.
• W2139510434 hasAuthorship W2139510434A5013706869 @default.
• W2139510434 hasAuthorship W2139510434A5014470885 @default.
• W2139510434 hasAuthorship W2139510434A5019140543 @default.
• W2139510434 hasAuthorship W2139510434A5024636761 @default.
• W2139510434 hasAuthorship W2139510434A5026911901 @default.
• W2139510434 hasAuthorship W2139510434A5040697066 @default.
• W2139510434 hasAuthorship W2139510434A5043776379 @default.
• W2139510434 hasAuthorship W2139510434A5049230032 @default.
• W2139510434 hasAuthorship W2139510434A5049493074 @default.
• W2139510434 hasAuthorship W2139510434A5055013606 @default.
• W2139510434 hasAuthorship W2139510434A5064069772 @default.
• W2139510434 hasAuthorship W2139510434A5073338995 @default.
• W2139510434 hasAuthorship W2139510434A5077277131 @default.
• W2139510434 hasAuthorship W2139510434A5078282647 @default.
• W2139510434 hasAuthorship W2139510434A5084017326 @default.
• W2139510434 hasConcept C121608353 @default.
• W2139510434 hasConcept C126322002 @default.
• W2139510434 hasConcept C141071460 @default.
• W2139510434 hasConcept C143998085 @default.
• W2139510434 hasConcept C146357865 @default.
• W2139510434 hasConcept C151730666 @default.
• W2139510434 hasConcept C2776694085 @default.
• W2139510434 hasConcept C2776755627 @default.
• W2139510434 hasConcept C2777757722 @default.
• W2139510434 hasConcept C2779572924 @default.
• W2139510434 hasConcept C3019096185 @default.
• W2139510434 hasConcept C509974204 @default.
• W2139510434 hasConcept C530470458 @default.
• W2139510434 hasConcept C71924100 @default.
• W2139510434 hasConcept C86803240 @default.
• W2139510434 hasConceptScore W2139510434C121608353 @default.
• W2139510434 hasConceptScore W2139510434C126322002 @default.
• W2139510434 hasConceptScore W2139510434C141071460 @default.
• W2139510434 hasConceptScore W2139510434C143998085 @default.
• W2139510434 hasConceptScore W2139510434C146357865 @default.
• W2139510434 hasConceptScore W2139510434C151730666 @default.
• W2139510434 hasConceptScore W2139510434C2776694085 @default.
• W2139510434 hasConceptScore W2139510434C2776755627 @default.

• next